HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Wingerd Selected Research

Mark Wingerd Research Topics

Disease

2Ischemia
11/2015 - 09/2013
2Acidosis
11/2015 - 09/2013
2Shock
11/2015 - 09/2013
1Hypoxia (Hypoxemia)
11/2015
1Hypotension (Low Blood Pressure)
11/2015
1Traumatic Shock
11/2015
1Hemorrhage
11/2015
1Hemorrhagic Shock
09/2013
1Reperfusion Injury
09/2013

Drug/Important Bio-Agent (IBA)

1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2015
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
11/2015
1Nitric Oxide Synthase (NO Synthase)IBA
11/2015
1salicylhydroxamic acid (SHAM)IBA
11/2015
1CyclodextrinsIBA
09/2013
1Crystalloid SolutionsIBA
09/2013
1Flutamide (Eulexin)FDA LinkGeneric
09/2013

Therapy/Procedure

2Resuscitation
11/2015 - 09/2013
1Laparotomy
11/2015
1Hemodilution
09/2013